Longboard Pharmaceuticals Statistics Share Statistics Longboard Pharmaceuticals has 39.05M
shares outstanding. The number of shares has increased by 0.38%
in one year.
Shares Outstanding 39.05M Shares Change (YoY) 0.38% Shares Change (QoQ) 0% Owned by Institutions (%) 99.99% Shares Floating 24.97M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 1.59M, so 4.07% of the outstanding
shares have been sold short.
Short Interest 1.59M Short % of Shares Out 4.07% Short % of Float 5.38% Short Ratio (days to cover) 1.93
Valuation Ratios The PE ratio is -2.52 and the forward
PE ratio is -18.57.
Longboard Pharmaceuticals's PEG ratio is
0.53.
PE Ratio -2.52 Forward PE -18.57 PS Ratio 0 Forward PS n/a PB Ratio 3.35 P/FCF Ratio -2.69 PEG Ratio 0.53
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Longboard Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 5.14,
with a Debt / Equity ratio of 0.01.
Current Ratio 5.14 Quick Ratio 5.14 Debt / Equity 0.01 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.09M Employee Count 50 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is 1.09, so Longboard Pharmaceuticals's
price volatility has been higher than the market average.
Beta 1.09 52-Week Price Change n/a 50-Day Moving Average 56.75 200-Day Moving Average 33.99 Relative Strength Index (RSI) 79.7 Average Volume (20 Days) n/a
Income Statement
Revenue n/a Gross Profit -5K Operating Income -56.76M Net Income -54.42M EBITDA -56.75M EBIT -56.76M Earnings Per Share (EPS) -2.39
Full Income Statement Balance Sheet The company has 14.33M in cash and 475K in
debt, giving a net cash position of 13.86M.
Cash & Cash Equivalents 14.33M Total Debt 475K Net Cash 13.86M Retained Earnings -140.56M Total Assets 297M Working Capital 274.68M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -50.87M
and capital expenditures 0, giving a free cash flow of -50.87M.
Operating Cash Flow -50.87M Capital Expenditures n/a Free Cash Flow -50.87M FCF Per Share -2.24
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
